A novel approach to the use of subgingival controlled - release chlorhexidine delivery in chronic periodontitis : a randomized clinical trial . 
<br>
<br> BACKGROUND We aimed to analyze <font color="red">clinical_1</font> <font color="red">,_1</font> <font color="red">microbiologic_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">serologic_1</font> <font color="red">effects_1</font> of chlorhexidine ( CHX ) chips used as a subgingival controlled - release delivery device before and immediately after scaling and root planing ( SRP ) . 
<br> METHODS Twenty - four patients presenting with ≥12 teeth with probing depth ( PD ) ≥5 mm and bleeding on probing were assigned in test or control groups . After prophylaxis , CHX chips ( test ) or placebo chips ( control ) were placed in pockets with PD ≥5 mm . Ten days later , SRP was performed in all teeth with PD ≥4 mm in a single appointment . Immediately after SRP , new chips were inserted in all pockets with PD ≥5 mm . Parameters were assessed at baseline ; beginning of SRP ; and 1 , 3 , and 6 months after treatment . Subgingival samples were obtained at baseline ; beginning of SRP ; and at 1 month after treatment . Periodontal pathogens <font color="red">Aggregatibacter_1</font> <font color="red">actinomycetemcomitans_1</font> <font color="red">,_1</font> <font color="red">Porphyromonas_1</font> <font color="red">gingivalis_1</font> <font color="red">,_1</font> <font color="red">Prevotella_1</font> <font color="red">intermedia_1</font> <font color="red">,_1</font> <font color="red">Tannerella_1</font> <font color="red">forsythia_1</font> <font color="red">,_1</font> and <font color="red">Treponema_1</font> <font color="red">denticola_1</font> were analyzed . <font color="red">Serum_1</font> <font color="red">levels_1</font> <font color="red">of_1</font> <font color="red">high_1</font> <font color="red">sensitive_1</font> <font color="red">C_1</font> <font color="red">-_1</font> <font color="red">reactive_1</font> <font color="red">and_1</font> <font color="red">lipopolysaccharide_1</font> <font color="red">-_1</font> <font color="red">binding_1</font> <font color="red">proteins_1</font> were measured . The changes of the parameters between and within the groups were tested by <font color="red">Mann_1</font> <font color="red">-_1</font> <font color="red">Whitney_1</font> <font color="red">U_1</font> <font color="red">test_1</font> ( P < 0.05 ) . 
<br> RESULTS All clinical and serologic parameters improved in both groups over time . There was a significant difference in <font color="red">clinical_1</font> <font color="red">attachment_1</font> <font color="red">level_1</font> <font color="red">(_1</font> <font color="red">CAL_1</font> <font color="red">)_1</font> gain from baseline to 6 months between groups ( 1.17 mm in the test group versus 0.79 mm in the placebo group ) ( P < 0.05 ) . The treatment with CHX chips showed a greater reduction of the <font color="red">microorganisms_1</font> <font color="red">of_1</font> <font color="red">the_1</font> <font color="red">"_1</font> <font color="red">red_1</font> <font color="red">complex_1</font> <font color="red">"_1</font> after 1 month ( P = 0.02 ) . 
<br> CONCLUSION The use of CHX chips before and immediately after SRP improved <font color="red">CAL_1</font> and reduced the <font color="red">subgingival_1</font> <font color="red">microorganisms_1</font> <font color="red">of_1</font> <font color="red">the_1</font> <font color="red">red_1</font> <font color="red">complex_1</font> in the treatment of chronic periodontitis .